Pro Medicus Croissance future

Future contrôle des critères 4/6

Pro Medicus devrait augmenter ses bénéfices et son chiffre d'affaires de 19.1% et de 17.1% par an respectivement. Le BPA devrait croître de de 19.1% par an. Le rendement des capitaux propres devrait être 47.8% dans 3 ans.

Informations clés

19.1%

Taux de croissance des bénéfices

19.1%

Taux de croissance du BPA

Healthcare Services croissance des bénéfices	20.8%
Taux de croissance des recettes	17.1%
Rendement futur des capitaux propres	47.8%
Couverture par les analystes	Good
Dernière mise à jour	18 Nov 2024

Mises à jour récentes de la croissance future

Recent updates

Shareholders Will Probably Hold Off On Increasing Pro Medicus Limited's (ASX:PME) CEO Compensation For The Time Being

Nov 18

Why The 47% Return On Capital At Pro Medicus (ASX:PME) Should Have Your Attention

Aug 12

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Jul 08

Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)

May 09

Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?

Apr 02

Pro Medicus (ASX:PME) Is Achieving High Returns On Its Capital

Jan 25

We Ran A Stock Scan For Earnings Growth And Pro Medicus (ASX:PME) Passed With Ease

Dec 13

Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)

Oct 26

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Sep 14

Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital

Jul 06

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Jun 15

Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?

Mar 16

Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital

Feb 23

Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?

Oct 26

Pro Medicus (ASX:PME) Knows How To Allocate Capital Effectively

Aug 13

Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?

Jul 26

Pro Medicus (ASX:PME) Is Investing Its Capital With Increasing Efficiency

May 07

Pro Medicus Limited's (ASX:PME) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 15

This Insider Has Just Sold Shares In Pro Medicus Limited (ASX:PME)

Feb 20

Pro Medicus Limited Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next

Feb 18

Is Pro Medicus (ASX:PME) The Next Multi-Bagger?

Feb 01

How Much Did Pro Medicus' (ASX:PME) CEO Pocket Last Year?

Jan 12

Should You Be Adding Pro Medicus (ASX:PME) To Your Watchlist Today?

Dec 28

Pro Medicus (ASX:PME) Has Rewarded Shareholders With An Exceptional 825% Total Return On Their Investment

Dec 11

Is Pro Medicus Limited's (ASX:PME) Shareholder Ownership Skewed Towards Insiders?

Nov 26

Pro Medicus's (ASX:PME) Earnings Are Growing But Is There More To The Story?

Aug 09

What Kind Of Shareholders Hold The Majority In Pro Medicus Limited's (ASX:PME) Shares?

Aug 09

Does Pro Medicus (ASX:PME) Have The DNA Of A Multi-Bagger?

Jul 21

How Much Are Pro Medicus Limited (ASX:PME) Insiders Taking Off The Table?

Jul 03

Prévisions de croissance des bénéfices et des revenus

ASX:PME - Estimations futures des analystes et données financières antérieures (AUD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
6/30/2027	316	174	158	167	12
6/30/2026	258	138	129	136	12
6/30/2025	210	109	102	107	12
6/30/2024	162	83	75	82	N/A
3/31/2024	152	76	70	77	N/A
12/31/2023	142	70	65	71	N/A
9/30/2023	134	65	60	67	N/A
6/30/2023	125	61	56	63	N/A
3/31/2023	115	56	51	59	N/A
12/31/2022	106	51	47	55	N/A
9/30/2022	100	48	50	58	N/A
6/30/2022	93	44	53	62	N/A
3/31/2022	87	41	47	55	N/A
12/31/2021	81	38	41	49	N/A
9/30/2021	74	34	36	44	N/A
6/30/2021	68	31	31	39	N/A
3/31/2021	64	28	27	36	N/A
12/31/2020	59	25	24	32	N/A
9/30/2020	58	24	24	32	N/A
6/30/2020	57	23	24	31	N/A
3/31/2020	55	23	25	33	N/A
12/31/2019	54	22	27	34	N/A
9/30/2019	52	21	22	30	N/A
6/30/2019	50	19	17	25	N/A
3/31/2019	47	17	N/A	N/A	N/A
12/31/2018	43	16	7	14	N/A
9/30/2018	39	13	7	14	N/A
6/30/2018	34	10	7	14	N/A
3/31/2018	33	9	N/A	N/A	N/A
12/31/2017	32	8	N/A	15	N/A
9/30/2017	32	9	N/A	15	N/A
6/30/2017	32	9	N/A	15	N/A
3/31/2017	30	9	N/A	13	N/A
12/31/2016	28	8	N/A	12	N/A
9/30/2016	28	7	N/A	11	N/A
6/30/2016	28	6	N/A	11	N/A
3/31/2016	25	5	N/A	9	N/A
12/31/2015	23	5	N/A	8	N/A
9/30/2015	20	4	N/A	6	N/A
6/30/2015	17	3	N/A	4	N/A
3/31/2015	17	3	N/A	4	N/A
12/31/2014	17	3	N/A	4	N/A
9/30/2014	16	2	N/A	4	N/A
6/30/2014	14	2	N/A	4	N/A
12/31/2013	11	1	N/A	6	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de PME ( 19.1% par an) est supérieure au taux d'épargne ( 2.6% ).

Bénéfices vs marché: Les bénéfices de PME ( 19.1% par an) devraient croître plus rapidement que le marché Australian ( 12.4% par an).

Croissance élevée des bénéfices: Les bénéfices de PME devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de PME ( 17.1% par an) devrait croître plus rapidement que le marché Australian ( 5.7% par an).

Croissance élevée des revenus: Le chiffre d'affaires de PME ( 17.1% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de PME devrait être très élevé dans 3 ans ( 47.8 %).

Pro Medicus Croissance future

Future contrôle des critères 4/6

Informations clés

Mises à jour récentes de la croissance future

Price target increased by 8.6% to AU$139

Price target increased by 15% to AU$123

Price target increased by 8.5% to AU$78.14

Price target increased by 7.4% to AU$67.29

Price target increased by 7.6% to AU$65.64

Price target increased to AU$52.25

Recent updates

Shareholders Will Probably Hold Off On Increasing Pro Medicus Limited's (ASX:PME) CEO Compensation For The Time Being

With EPS Growth And More, Pro Medicus (ASX:PME) Makes An Interesting Case

Price target increased by 8.6% to AU$139

Pro Medicus Limited, Annual General Meeting, Nov 25, 2024

Upcoming dividend of AU$0.22 per share

Final dividend of AU$0.22 announced

New major risk - Earnings quality

Price target increased by 15% to AU$123

Full year 2024 earnings: EPS exceeds analyst expectations

Pro Medicus Limited to Report Fiscal Year 2024 Results on Aug 14, 2024

Do Pro Medicus' (ASX:PME) Earnings Warrant Your Attention?

Upcoming dividend of AU$0.18 per share

First half dividend of AU$0.18 announced

First half 2024 earnings: EPS misses analyst expectations

Pro Medicus Limited to Report First Half, 2024 Results on Feb 15, 2024

Here's Why We Think Pro Medicus (ASX:PME) Might Deserve Your Attention Today

Price target increased by 8.5% to AU$78.14

Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital

Co-Founder recently sold AU$88m worth of stock

New minor risk - Insider selling

Pro Medicus Limited, Annual General Meeting, Nov 20, 2023

Here's Why Pro Medicus (ASX:PME) Has Caught The Eye Of Investors

Insufficient new directors

Upcoming dividend of AU$0.17 per share at 0.5% yield

Price target increased by 7.4% to AU$67.29

New major risk - Earnings quality

Price target increased by 7.6% to AU$65.64

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Why The 47% Return On Capital At Pro Medicus (ASX:PME) Should Have Your Attention

Pro Medicus Limited to Report Fiscal Year 2023 Final Results on Aug 15, 2023

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)

Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?

Chairman recently sold AU$3.1m worth of stock

Upcoming dividend of AU$0.13 per share at 0.4% yield

First half 2023 earnings: EPS in line with analyst expectations despite revenue beat

Pro Medicus Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 24, 2023

Pro Medicus (ASX:PME) Is Achieving High Returns On Its Capital

Pro Medicus Limited to Report First Half, 2023 Results on Feb 15, 2023

We Ran A Stock Scan For Earnings Growth And Pro Medicus (ASX:PME) Passed With Ease

Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)

Pro Medicus Limited, Annual General Meeting, Nov 21, 2022

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Upcoming dividend of AU$0.12 per share

Full year 2022 earnings: EPS misses analyst expectations

Pro Medicus Limited Announces Fully Franked Ordinary Dividend for the Period of Twelve Months Ended June 30, 2022, Payable on September 30, 2022

Pro Medicus Limited to Report Q4, 2022 Results on Aug 18, 2022

Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?

Upcoming dividend of AU$0.10 per share

Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital

First half 2022 earnings: EPS and revenues exceed analyst expectations

Pro Medicus Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 25, 2022

Pro Medicus Limited to Report First Half, 2022 Results on Feb 16, 2022

Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?

Upcoming dividend of AU$0.08 per share

Price target increased to AU$52.25

Full year 2021 earnings released: EPS AU$0.30 (vs AU$0.22 in FY 2020)

Pro Medicus (ASX:PME) Knows How To Allocate Capital Effectively

Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?

Pro Medicus (ASX:PME) Is Investing Its Capital With Increasing Efficiency

Pro Medicus Limited's (ASX:PME) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Co-Founder recently sold AU$46m worth of stock

This Insider Has Just Sold Shares In Pro Medicus Limited (ASX:PME)

First half 2021 earnings released: EPS AU$0.13 (vs AU$0.12 in 1H 2020)

Revenue and earnings miss expectations

Pro Medicus Limited Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next

Price target raised to AU$40.82